Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drug store sales

This article was originally published in The Tan Sheet

Executive Summary

OTC sales in community pharmacies are expected to rise 8.3% to $32 bil. in 1999, compared to sales of $29.5 bil. in 1998, NACDS Interim President and CEO Robert Hannan stated at the trade group's pharmacy and managed care forum in San Diego Aug. 29-Sept. 1. Traditional chain pharmacies and mass merchant pharmacies each are expected to make up 32.5% of that total, or $10.4 bil., while supermarket pharmacies contribute 30.9% ($9.9 bil.) and independent outlets add 4.1% ($1.3 bil.). The most growth, 11.1%, is predicted for mass merchant stores. Meanwhile, Rx sales are expected to rise 18% over 1998 levels, totaling $121.6 bil

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090276

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel